Richard Wurtman

Richard Wurtman
Born	March 9, 1936 (1936-03-09) (age 81) Philadelphia, Pennsylvania, United States
Fields	Neuroscience, Treatments for Brain Diseases, Nutrition and the Brain
Institutions	MIT, Harvard
Alma mater	University of Pennsylvania (BA) Harvard Medical School (MD) Training in Medicine and Endocrinology, Massachusetts General Hospital Research Training, National Institutes of Health
Known for	Invention of use of melatonin to promote sleep Use of serotoninergic drugs to treat obesity and other disorders characterized by disturbances in both appetite and mood Strategies for finding drugs to treat Alzheimer's Disease; (Wurtman, 2009) Use of their circulating precursors to increase the syntheses of brain neurotransmitters and membranes

Richard Wurtman, M.D., is the Cecil H. Green Distinguished Professor at the Massachusetts Institute of Technology and a Professor of Neuroscience in MIT’s Department of Brain & Cognitive Sciences, and of Neuropharmacology in the Harvard – MIT Division of Health Sciences & Technology.

His research career encompasses three areas:

Research performed in Wurtman's laboratory has generated about 1,000 research articles and 200 patents.

Among discoveries from Wurtman's laboratory have been that

With wife Judith Wurtman, Wurtman co-edited an eight-volume series of books on “Nutrition and the Brain”, and with John Growdon, M.D. and Suzanne Corkin, Ph.D., a nine volume series on Alzheimer’s disease.

Wurtman co-founded Interneuron Pharmaceuticals in 1988, which was renamed to Indevus in 2002. Indevus brought an in-licensed product, Trospium chloride, to market before being acquired by Endo Pharmaceuticals in 2009 for $370.0M in cash and $267.0M in milestones.

He also founded Back Bay Scientific, Inc..

He established the Center for Brain Sciences and Metabolism Charitable Trust, and serves as its Scientific Director.

Among Wurtman's publications are the following (see external links below for the link to a pdf file of a more complete list):

...
Wikipedia